1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Regulation

FDA Contracting Out Research On 25 Cosmetic Ingredients’ Allergenicity

 
• By Ryan Nelson

Agency is accepting contractor proposals through August 11 for a scientific literature survey and data analysis to determine whether 25 cosmetic ingredients/mixtures warrant identification as “sensitizers” or “allergens,” according to definitions being developed separately. Preservatives dominate the list.

FDA is soliciting proposals for contract research to assess the allergenicity and sensitization potential of 25 cosmetic ingredients/mixtures – mostly preservatives – based on published scientific data and consensus-backed definitions.

“In order to develop a regulatory position that is based on the most relevant scientific literature, the FDA needs a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 
• By Eileen Francis

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.

Beauty Industry: Counter Impact Of State Legislation By Connecting With Lawmakers – IBA

 
• By Eileen Francis

Beauty stakeholders will undoubtedly feel the impact of new state laws targeting cosmetic ingredients and packaging and should therefore open lines of communication with state lawmakers.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By Sue Sutter

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.